In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

Novartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, ...

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Novartis (NVS) raised its full-year profit outlook thanks to strong demand for some of its key drugs. Novartis CEO Vas ...

By Miranda Murray and Patricia Weiss BERLIN (Reuters) -Swiss drugmaker Novartis nudged up its full-year earnings forecast on ...

Johnson & Johnson (J&J) has halved its expectations for costs this year related to new tariffs and raised its full-year sales ...

Rather than continuing to retaliate with tariffs of its own, the Canadian government has begun to confess that such a tactic ...

The Cold Storage market is poised for significant growth due to increased demand for temperature-controlled logistics in food ...

Oil prices rose $1 on Thursday after drones struck Iraqi Kurdistan oil fields for a fourth day, pointing to continued risk in ...

(Reuters) -European shares rose on Friday, on course for small weekly gains, as investors focussed on corporate earnings for ...

Asian countries are offering to buy more U.S. liquefied natural gas to ease trade tensions with the Trump administration. Countries like Vietnam, Japan, and South Korea are mulling long-term LNG ...